Luke Lee, FSIArb

International Arbitration Lawyer | Building Donna AI® - the world’s first AI-native legal OS.

London, England, United Kingdom

About

Luke is a Director at BR Law Corporation. His disputes practice encompasses international commercial arbitration, arbitration-related litigation, enforcement of arbitral awards and foreign judgments, and urgent interim and injunctive relief in complex commercial matters. He regularly represents state-linked entities, multinational corporations and high-net-worth individuals across Asia. He holds an LL.M (Distinction) in International Dispute Resolution from King’s College London, where he was top in cohort for Enterprise Law and achieved First Class marks in International Commercial Arbitration (Dissertation), International Dispute Resolution, FinTech law, and Transnational Human Rights Litigation. Luke is a Fellow of the Singapore Institute of Arbitrators, an Accredited Mediator with the Singapore International Mediation Institute, and a member of the Singapore Chamber of Maritime Arbitration. He is empanelled as Neutral on the Law Society's LSNEDS-FIDReC Panel of Neutrals and as International Mediator on the Sage Mediation International Mediators Panel. He serves as Assistant Editor of the Singapore Arbitration Journal and sits on the SIArb’s Arbitration Bar Committee. He has contributed to law reform efforts, including the Ministry of Law consultation on the International Arbitration Act following the SIDRA Review. He regularly appears as counsel in SIAC arbitrations and before the Singapore courts, including the High Court and the Singapore International Commercial Court, often in matters involving parallel proceedings and multi-jurisdictional enforcement considerations. Luke has particular expertise in disputes arising from cross-border investments, financing arrangements and large-scale infrastructure and energy projects. He is frequently engaged in matters involving complex contractual structures, and issues of jurisdiction, governing law and enforcement strategy. He advises clients on regulatory and risk issues in the technology and digital assets space, particularly where such issues intersect with cross-border disputes. His research focuses on the intersection of law and technology, including artificial intelligence and digital asset regulation. His papers have been cited internationally in over 70 academic publications. He is a regular speaker at conferences and academic institutions, including the National University of Singapore, Singapore Management University, GLA Arbitration & Litigation Conference (Kuala Lumpur), and hosted and spoke at the Law Society of Singapore’s Public Law Conference.

Experience

  • BR Law Corporation (2 yrs)
    • Director (International Arbitration & Dispute Resolution)
      Apr 2026 - Present · 3 mos

    • Associate Director (International Arbitration & Dispute Resolution)
      Jul 2024 - Mar 2026 · 1 yr 9 mos

  • Chief Executive Officer at Vanguard AI®
    2023 - Present · 3 yrs 6 mos

    - Vanguard AI® is a legaltech artificial intelligence company developing AI-native data infrastructure for legal teams. - With offices in Singapore, Hong Kong, London, and the US, Vanguard AI® is dedicated to transforming the legal industry, making it more efficient, effective, and accessible. - Vanguard AI® constitutes a law-related service under Rule 34(3) read with the Fourth Schedule of the Legal Profession (Professional Conduct) Rules 2015.

  • Investor at Atom Limbs
    2024 - Present · 2 yrs 6 mos

    - World's first mind-controlled robotic arm with individual finger control & sense of touch in a $2T market ripe for disruption. The Atom Touch artificial arm is a groundbreaking, non-invasive, neurally-controlled wearable robotic system with control made possible by sEMG and machine learning. - Backed by Moai Capital, J4 Ventures, notable angels include YC Co-Founder Trevor Blackwell & Anthony Pompliano.

  • Lawyer at Called to the Singapore Bar
    Sep 2018 - Present · 7 yrs 10 mos

    - Called to the Singapore Bar as an Advocate & Solicitor of the Supreme Court of Singapore.

  • Investor at Pirouette Medical
    2024 - Present · 2 yrs 6 mos

    - Pirouette Medical (YC S21)'s patented auto-injector technology is designed to deliver life-saving medications safely and easily. Pirouette's flagship epinephrine and naloxone auto-injector, QuicPush, is the world's only intramuscular injector with a 2-inch diameter stable base. - Pirouette is set to revolutionise health in a $600B injectable drug delivery market. - Backed by Y Combinator & leading VCs including Safar Partners, Liquid 2 Ventures, & Gaingels.